Alexis Viel

Dr. Alexis Viel

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 September 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ASApolline Salama
Apolline Salama
NFNolwenn Fichou
Nolwenn Fichou
MAMarie Allard
Marie Allard
LDLaurence Dubreil
Laurence Dubreil
LBLaurence De Beaurepaire
Laurence De Beaurepaire
JBJean-Marie Bach
Jean-Marie Bach
In addition to important regulatory roles in gene expression through RNA interference, it has recently been shown that microRNAs display immune stimulatory effects through direct interaction with receptors of innate immunity of the Toll-like receptor family, aggravating neuronal damage and tumour growth. Yet no evidence exists on consequences of microRNA immune stimulatory actions in the context of an autoimmune disease. Using microRNA analogues, we here show that pancreatic beta cell-derived microRNA sequences induce pro-inflammatory (TNFa, IFNa, IL-12, IL-6) or suppressive (IL-10) cytokine secretion by primary mouse dendritic cells in a sequence-dependent manner. For miR-29b, immune stimulation in RAW264.7 macrophages involved the endosomal Toll-like receptor-7, independently of the canonical RNA interference pathway. In vivo, the systemic delivery of miR-29b activates CD11b+B220− myeloid and CD11b-B220+ plasmacytoid dendritic cells and induces IFNa, TNFa and IL-6 production in the serum of recipient mice. Strikingly, in a murine model of adoptive transfer of autoimmune diabetes, miR-29b reduces the cytolytic activity of transferred effector CD8+ T-cells, insulitis and disease incidence in a single standalone intervention. Endogenous miR-29b, spontaneously released from beta-cells within exosomes, stimulates TNFa secretion from spleen cells isolated from diabetes-prone NOD mice in vitro. Hence, microRNA sequences modulate innate and ongoing adaptive immune responses raising the question of their potential role in the breakdown of tolerance and opening up new applications for microRNA-based immune therapy.

7 February 2022 in Food and Chemical Toxicology
Verified
Journal Article
Open access
JTJennifer Tardiveau
Jennifer Tardiveau
LLLerica LeRoux-Pullen
Lerica LeRoux-Pullen
RGRonette Gehring
Ronette Gehring
GTGaël Touchais
Gaël Touchais
MCMarie Pierre Chotard-Soutif
Marie Pierre Chotard-Soutif
NGNicolas Grégoire
Nicolas Grégoire
Antibiotic excretion into milk depends on several factors such as the compound's physicochemical properties, the animal physiology, and the milk composition. The objective of this study was to develop a physiologically based pharmacokinetic (PBPK) model describing the passage of drugs into the milk of lactating species. The udder is described as a permeability limited compartment, divided into vascular, extracellular water (EW), intracellular water (IW) and milk, which was stored in alveolar and cistern compartments. The pH and ionization in each compartment and the binding to IW components and to milk fat, casein, whey protein, calcium, and magnesium were considered. Bidirectional passive diffusion across the blood-milk barrier was implemented, based on in vitro permeability studies. The model application used to predict the distribution of oxytetracycline in cow and goat milk, after different doses and routes of administration, was successful. By integrating inter-individual variability and uncertainty, the model also allowed a suitable estimation of the withdrawal periods. Further work is in progress to evaluate the predictive ability of the PBPK model for compounds with different physico-chemical properties that are potentially actively transported in order to extrapolate the excretion of xenobiotics in milk of various animal species including humans.

8 August 2024 in Poultry Science
Verified
Journal Article
Open access
MBMarine Boulanger
Marine Boulanger
JTJean-François Taillandier
Jean-François Taillandier
JHJerome Henri
Jerome Henri
MDMathias Devreese
Mathias Devreese
SBSiegrid De Baere
Siegrid De Baere
AVAlexis Viel
Alexis Viel
Sulfonamides (S) are old bacteriostatic antibiotics which are widely prescribed in combination with trimethoprim (TMP) for the treatment of various diseases in food-producing animals such as poultry. Nowadays, the 1:5 dose ratio of TMP/S used in broilers is a direct transposition of the ratio determined in Human decades ago for TMP/sulfamethoxazole (SMX), aiming to obtain a supposed synergistic plasma concentration ratio of 1:19. However, major pharmacokinetics (PK) differences exist according to the sulfonamide used in the combination. Here, we generated new PK data in broilers after a cross-over design with IV and the oral administration of 2 major sulfonamides, sulfadiazine (SDZ) and SMX, in combination with TMP, and analyzed the data via a population pharmacokinetic (popPK) modeling approach. Results showed that TMP has a greater plasma to tissue distribution than both sulfonamides with a higher volume of distribution (0.51 L/kg for SDZ, 0.62 L/kg for SMX and 3.14 L/kg for TMP). SMX has the highest elimination half-life (2.83 h) followed by SDZ and TMP (2.01 h and 1.49 h, respectively). The oral bioavailability of the 3 molecules was approximately 100%. Bodyweight could explain some of the inter-individual variability in the volume of distribution of SDZ and SMX and the clearance of SDZ and TMP, as heavier broilers have higher typical values. Monte Carlo simulations of a large virtual broiler population (n = 1,000) showed that the targeted plasma ratio of TMP:S of 1:19 was rarely or never reached at the individual level for both combinations at the marketed doses and greatly varies over time and between individuals, questioning the relevance of the 1:5 dose ratio for current formulations of TMP/S.

12 March 2018 in Pharmaceutical Research
Verified
Journal Article
Closed access
PDF file
AVAlexis Viel
Alexis Viel
JHJerome Henri
Jerome Henri
SBSalim Bouchène
Salim Bouchène
JLJulian Laroche
Julian Laroche
JRJean-Guy Rolland
Jean-Guy Rolland
NGNicolas Grégoire
Nicolas Grégoire

21 October 2022 in Poultry Science
Verified
Journal Article
Open access
ABAbubakar Bello
Abubakar Bello
JHJerome Henri
Jerome Henri
AVAlexis Viel
Alexis Viel
Jonathan MochelJonathan Mochel
Jonathan Mochel
BPBłażej Poźniak
Błażej Poźniak
Poultry production is linked with the use of veterinary medicinal products to manage diseases. Ionophore coccidiostats have been permitted for use as feed additives within the European Union (EU) for the prevention of coccidiosis in various species of poultry with except of laying hens. The presence of chemical residues in eggs is a matter of major concern for consumers' health. Despite such prohibition of use in laying hens, they were identified as the most common non-target poultry species being frequently exposed to these class of coccidiostats. Many factors can influence the presence of residues in eggs. Carryover of these class of coccidiostat feed additives in the feed of laying hens has been identified as the main reason of their occurrence in commercial poultry eggs. The physicochemical properties of individual compounds, the physiology of the laying hen, and the biology of egg formation are believed to govern the residue transfer rate and its distribution between the egg white and yolk compartments. This paper reviews the causes of occurrence of residues of ionophore coccidiostats in eggs within the EU with special emphasis on their disposition kinetics in laying hens, and residue transfer into eggs. Additional effort was made to highlight future modeling perspectives on the potential application of pharmacokinetic modeling in predicting drug residue transfer and its concentration in eggs.

16 December 2022 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Closed access
EDEstelle Dréano
Estelle Dréano
CVCharlotte Valentin
Charlotte Valentin
JTJean-François Taillandier
Jean-François Taillandier
ATAngélique Travel
Angélique Travel
CSChristophe Soumet
Christophe Soumet
SMSOPHIE Mompelat
SOPHIE Mompelat